Oxford Asset Management’s Novavax NVAX Stock Holding History

Oxford Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$161K	Sell	19,783 -1,728	-8%	-$15.7K	0.07%	379
2025 Q4	$145K	Buy	+21,511	New	+$162K	0.05%	415
2018 Q3	–	Sell	-26,181	Closed	-$699K	–	1861
2018 Q2	$699K	Buy	26,181 +21,274	+434%	+$719K	0.01%	1214
2018 Q1	$206K	Sell	4,907 -5,353	-52%	-$215K	﹤0.01%	1483
2017 Q4	$267K	Buy	+10,260	New	+$250K	0.01%	1367
2017 Q1	–	Sell	-4,236	Closed	-$107K	–	1450
2016 Q4	$107K	Sell	4,236 -29,189	-87%	-$851K	﹤0.01%	731
2016 Q3	$1.39M	Buy	+33,425	New	+$4.32M	0.04%	465
2016 Q1	–	Sell	-4,874	Closed	-$812K	–	861
2015 Q4	$812K	Sell	4,874 -3,751	-43%	-$577K	0.02%	583
2015 Q3	$1.22M	Buy	+8,625	New	+$1.93M	0.04%	372

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oxford Asset Management's NVAX Position: Q1 2026 in Review

Oxford Asset Management reduced its Novavax (NVAX) stake by 8% in Q1 2026, selling an estimated $15.7K and leaving 19,783 shares worth $161K. The position accounts for 0.07% of the portfolio, ranked #379.

Oxford Asset Management first reported a position in NVAX in Q3 2015 and has held it in 9 quarters since. The position peaked at $1.39M in Q3 2016. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

Oxford Asset Management held 19,783 shares of Novavax worth $161K as of Q1 2026.
Oxford Asset Management sold 1,728 Novavax shares in Q1 2026, an estimated $15.7K.
Novavax made up 0.07% of Oxford Asset Management's portfolio in Q1 2026, its #379 holding.
Oxford Asset Management first reported a position in Novavax in Q3 2015 and has held it in 9 quarters since.
Oxford Asset Management's Novavax position peaked at $1.39M in Q3 2016.
257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Oxford Asset Management's 13F filing for Q1 2026, filed 15 May 2026.